EFDID: 94335EFD: View Filing

Issuer: Avalanche Biotechnologies, Inc. (0001501756) - D

Accession: 0001501756-14-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001501756
  • Entity Name:
    Avalanche Biotechnologies, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    1035 O'Brien Drive
    Menlo Park, CA 94025
  • Persons:
    Related Persons 5
    Thomas W. Chalberg
    Executive OfficerDirector
    Mark S. Blumenkranz
    Director
    Steven D. Schwartz
    Director
    John McLaughlin
    Director
    Paul D. Wachter
    Director
EDGAR: Offering Information
  • Accession Date:
    04/28/2014
  • First Sale Date:
    04/16/2014
  • Offering Amount:
    $55,978,020
  • Amount Sold:
    $55,127,152
  • Amount Remaining:
    $850,868
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Cowen and Company, LLC None None None CA, CT, NY
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Avalanche Biotechnologies, Inc./s/ Thomas W. ChalbergThomas W. Chalberg, Ph.D.President & Chief Executive Officer2014-04-28